Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds

dosimetry

  • Phase I Study of <sup>68</sup>Ga-NOTA-HL for PET/CT Imaging of Hepatic Asialoglycoprotein Receptors in Healthy Volunteers
    You have access
    Phase I Study of 68Ga-NOTA-HL for PET/CT Imaging of Hepatic Asialoglycoprotein Receptors in Healthy Volunteers
    Ching-Liang Kuo, Rhoh-Fang Yen, Yao-Ming Wu and Mei-Hui Wang
    Journal of Nuclear Medicine Technology May 9, 2025, jnmt.124.268430; DOI: https://doi.org/10.2967/jnmt.124.268430
  • You have access
    SNMMI Clinical Trials Network Research Series for Technologists: An Introduction to Conducting Theranostic Clinical Trials
    Freddy Gonzalez, Peter J.H. Scott, Charlotte Denise Jeffers and S. Cheenu Kappadath
    Journal of Nuclear Medicine Technology September 1, 2024, 52 (3) 184-191; DOI: https://doi.org/10.2967/jnmt.123.266588
  • First-Strike Rapid Predictive Dosimetry and Dose Response for <sup>177</sup>Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    You have access
    First-Strike Rapid Predictive Dosimetry and Dose Response for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Yung Hsiang Kao, Nadia Falzone, Michael Pearson and Dinesh Sivaratnam
    Journal of Nuclear Medicine Technology September 1, 2024, 52 (3) 212-218; DOI: https://doi.org/10.2967/jnmt.123.267067
  • You have access
    The MIRD Schema for Radiopharmaceutical Dosimetry: A Review
    Pat Zanzonico
    Journal of Nuclear Medicine Technology June 1, 2024, 52 (2) 74-85; DOI: https://doi.org/10.2967/jnmt.123.265668
  • Report on the PET/CT Image–Based Radiation Dosimetry of [<sup>18</sup>F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast Cancer
    You have access
    Report on the PET/CT Image–Based Radiation Dosimetry of [18F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast Cancer
    Keisha C. McCall, Mofei Liu, Su-Chun Cheng, Amanda Abbott, Shipra Dubey, Diane Young, Mayzie Johnston, Annick D. Van den Abbeele, Beth Overmoyer and Heather Jacene
    Journal of Nuclear Medicine Technology September 1, 2023, 51 (3) 204-210; DOI: https://doi.org/10.2967/jnmt.123.265623
  • You have access
    Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
    Diane K. Soulek, Molly E. Martin, Nic J. Mastascusa and Stephen A. Graves
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 195-202; DOI: https://doi.org/10.2967/jnmt.122.263813
  • Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy
    You have access
    Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy
    Caio Vinicius Oliveira, Tatiane Sabriela Cagol Camozzato, Patricia Fernanda Dorow and Jéssica Pasqueta
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 233-239; DOI: https://doi.org/10.2967/jnmt.121.263502
  • You have access
    Biodistribution and Dosimetry of Indigenously Produced 131I-Rituximab in B-Cell Lymphoma: Pilot Study Estimating Patient-Specific Dose Comparing 2 Different Dosimetric Methods
    Aadil Adnan, Kamal Deep, Mythilli Kameswaran, Dilip Nikam, Chandrakala Shanmukaih, Ashutosh Dash, Sharmila Banerjee and Sandip Basu
    Journal of Nuclear Medicine Technology December 1, 2019, 47 (4) 292-299; DOI: https://doi.org/10.2967/jnmt.118.216754
  • You have access
    Effective Dose in Nuclear Medicine Studies and SPECT/CT: Dosimetry Survey Across Quebec Province
    Mathieu Charest and Chantal Asselin
    Journal of Nuclear Medicine Technology June 1, 2018, 46 (2) 107-113; DOI: https://doi.org/10.2967/jnmt.117.202879
  • You have access
    Determining the Minimal Required Radioactivity of 18F-FDG for Reliable Semiquantification in PET/CT Imaging: A Phantom Study
    Ming-Kai Chen, David H. Menard and David W. Cheng
    Journal of Nuclear Medicine Technology March 1, 2016, 44 (1) 26-30; DOI: https://doi.org/10.2967/jnmt.115.165258

Pages

  • Next
  • 1
  • 2
SNMMI

© 2025 SNMMI

Powered by HighWire